Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Fessler

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Diabetes|January 10, 2012
CGI-58/ABHD5-derived signaling lipids regulate systemic inflammation and insulin actionCaleb C Lord, Jenna L Betters, Pavlina T Ivanova, et al.
Biochemical Pharmacology|January 19, 2026
Metabolic activation of lumisterol to biologically active metabolites and their mechanism of actionAndrzej T Slominski, Tae-Kang Kim, Zorica Janjetovic, et al.
JCI Insight|April 29, 2020
Cholesterol 25-hydroxylase promotes efferocytosis and resolution of lung inflammationJennifer H Madenspacher, Eric D Morrell, Kymberly M Gowdy, et al.
Frontiers in Genetics|July 7, 2023
Race/ethnicity-stratified fine-mapping of the MHC locus reveals genetic variants associated with late-onset asthmaEunice Y Lee, Wonson Choi, Adam B Burkholder, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 27, 2023
The prohibitin complex regulates macrophage fatty acid composition, plasma membrane packing, and lipid raft-mediated inflammatory signalingChristine E Psaltis Matthews, Lynn A Fussner, Michael Yaeger, et al.
Annals of the American Thoracic Society|June 2, 2017
An Official American Thoracic Society Workshop Report: Obesity and Metabolism. An Emerging Frontier in Lung Health and DiseaseBenjamin T Suratt, Niki D J Ubags, Deepa Rastogi, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisYosuke Sakamachi, Emma Wiley, Alma Solis, et al.
Science Translational Medicine|June 3, 2026
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPFYosuke Sakamachi, Emma Wiley, Carol S Trempus, et al.
American Journal of Respiratory Cell and Molecular Biology|February 1, 2022
Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop ReportHrishikesh S Kulkarni, Janet S Lee, Julie A Bastarache, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Diabetes|January 10, 2012
CGI-58/ABHD5-derived signaling lipids regulate systemic inflammation and insulin actionCaleb C Lord, Jenna L Betters, Pavlina T Ivanova, et al.
Biochemical Pharmacology|January 19, 2026
Metabolic activation of lumisterol to biologically active metabolites and their mechanism of actionAndrzej T Slominski, Tae-Kang Kim, Zorica Janjetovic, et al.
JCI Insight|April 29, 2020
Cholesterol 25-hydroxylase promotes efferocytosis and resolution of lung inflammationJennifer H Madenspacher, Eric D Morrell, Kymberly M Gowdy, et al.
Frontiers in Genetics|July 7, 2023
Race/ethnicity-stratified fine-mapping of the MHC locus reveals genetic variants associated with late-onset asthmaEunice Y Lee, Wonson Choi, Adam B Burkholder, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 27, 2023
The prohibitin complex regulates macrophage fatty acid composition, plasma membrane packing, and lipid raft-mediated inflammatory signalingChristine E Psaltis Matthews, Lynn A Fussner, Michael Yaeger, et al.
Annals of the American Thoracic Society|June 2, 2017
An Official American Thoracic Society Workshop Report: Obesity and Metabolism. An Emerging Frontier in Lung Health and DiseaseBenjamin T Suratt, Niki D J Ubags, Deepa Rastogi, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisYosuke Sakamachi, Emma Wiley, Alma Solis, et al.
Science Translational Medicine|June 3, 2026
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPFYosuke Sakamachi, Emma Wiley, Carol S Trempus, et al.
American Journal of Respiratory Cell and Molecular Biology|February 1, 2022
Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop ReportHrishikesh S Kulkarni, Janet S Lee, Julie A Bastarache, et al.
Pageof 15